N-cyclopropyl-o-toluenesulfonamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-cyclopropyl-o-toluenesulfonamide
• 英文别名: N-cyclopropyl-2-methylbenzenesulfonamide
• 化学式: C₁₀H₁₃NO₂S
• 分子量: 211.285
• InChiKey: YZQITOAGYNDPHJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  54.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-cyclopropyl-o-toluenesulfonamide 在 chromium(VI) oxide 、 高碘酸 作用下， 以 乙腈 为溶剂， 反应 16.0h， 以46%的产率得到N-cyclopropyl-1,2-benzisothiazol-3-one-1,1-dioxide
  参考文献：
  名称：

  Oxidative cyclization of N-alkyl-o-methyl-arenesulfonamides to biologically important saccharin derivatives

  摘要：

  Various biologically important saccharin skeletons and their N-alkyl derivatives have been efficiently prepared by chromium(VI) oxide catalyzed H5IO6 oxidation of N-alkyl-o-methyl-arenesulfonamides in acetonitrile. N-tert-Butyl saccharin skeletons were easily prepared by H5IO6-CrO3 oxidation of N-tert-butyl-o-methyl arenesulfonamides in the presence of acetic anhydride. The method that furnished the novel fluoro and trifluoromethyl substituted saccharin skeletons is characterized by two steps, a simple work-up procedure, a single purification and good overall yields from substituted toluene derivatives. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2006.05.038
• 作为产物：
  描述：

  环丙胺 、 邻甲苯磺酰氯 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 N-cyclopropyl-o-toluenesulfonamide
  参考文献：
  名称：

  N,N'-环状偶氮甲碱亚胺与 N-磺酰基环丙胺的自由基顺式选择性环化

  摘要：

  甲亚胺亚胺，广泛称为 1,3-偶极子，通过主要一致的或离子途径有效地产生合成和生物学上重要的二氮稠合杂环。在此，我们首次描述了利用可见光光氧化还原催化的偶氮甲碱亚胺的自由基成环。该策略能够合成传统上难以获得的二氮稠合饱和六元环状产物。值得注意的是，我们的过程表现出卓越的顺式非对映选择性，由异头效应控制。初步的机理研究揭示了一个串联过程，包括分子间自由基加成和分子内 6- exo -trig 环化。这项工作说明了涉及偶氮甲碱亚胺的可见光驱动的自由基环化反应领域的潜力。

  DOI：

  10.1021/acs.orglett.3c03180

文献信息

• Substituierte Prop-2-in-1-ol- und Prop-2-en-1-ol-Derivate
  申请人：Bayer CropScience AG

  公开号：EP2510786A1

  公开（公告）日：2012-10-17

  Die Erfindung betrifift substituierte Prop-2-in-1-ol- und Prop-2-en-1-ol-Derivate der allgemeinen Formel (I), wobei die Reste R1, R2, R3, R4, R5, [X-Y] und Q die in der Beschreibung angegebenen Definitionen besitzen, Verfahren zu deren Herstellung und ihre Verwendung zur Steigerung der Stresstoleranz in Pflanzen gegenüber abiotischem Stress, sowie zur Stärkung des Pflanzenwachstums und/oder zur Erhöhung des Pflanzenertrags.

  本发明涉及通式（I）的取代丙-2-烯-1-醇和丙-2-烯-1-醇衍生物、 其中自由基 R1、R2、R3、R4、R5、[X-Y] 和 Q 的定义见说明、 它们的制备工艺及其在提高植物对非生物性胁迫的耐受性以及促进植物生长和/或提高植物产量方面的用途。
• SUBSTITUIERTE VINYL- UND ALKINYL-CYANOCYCLOALKANOLE SOWIE VINYL- UND ALKINYL-CYANOHETEROCYCLYLALKANOLE ALS WIRKSTOFFE GEGEN ABIOTISCHEN PFLANZENSTRESS
  申请人：Bayer CropScience Aktiengesellschaft

  公开号：EP3169662B1

  公开（公告）日：2018-07-11
• [EN] SUBSTITUTED 2-MORPHOLINOPYRIDINE DERIVATIVES AS ATR KINASE INHIBITORS<br/>[FR] DÉRIVÉS 2-MORPHOLINOPYRIDINE SUBSTITUÉS UTILISÉS EN TANT QU'INHIBITEURS DE KINASES ATR
  申请人：REPARE THERAPEUTICS INC

  公开号：WO2021012049A1

  公开（公告）日：2021-01-28

  Disclosed are compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein — is a single bond, and each Y is N or CR4; or — is absent, and each Y is NRY, carbonyl, or C(RY)2, wherein each R1 is H or optionally substituted C1-6 alkyl; R1 is optionally substituted C1-6 alkyl or H; R3 is optionally substituted C1-9 heteroaryl or optionally substituted C1-9 heteroarylC1-6 alkyl; each R4 is hydrogen, halogen, optionally substituted C1-6 alkyl, optionally substituted C2-6 alkenyl, or optionally substituted C2-6 alkynyl; X is hydrogen or halogen; and R2 is as defined in claim 1. Also disclosed are pharmaceutical compositions containing the compounds of formula (I) and methods for their preparation. The compounds of formula (I) may be inhibitors of Ataxia-telangiectasia and RAD-3 -related protein kinase (ATR) and used for the treatment of diseases or conditions such as cancers.
• [EN] USE OF ATR INHIBITORS IN COMBINATION WITH PARP INHIBITORS<br/>[FR] UTILISATION D'INHIBITEURS D'ATR EN ASSOCIATION AVEC DES INHIBITEURS DE PARP
  申请人：REPARE THERAPEUTICS INC

  公开号：WO2021119523A1

  公开（公告）日：2021-06-17

  Disclosed are methods of treating a cancer in a subject using an ATR inhibitor and PARP inhibitor, wherein the cancer has been previously identified as a cancer having a loss of function of ATM, BRCA2, RNAse H2A, RNAse H2B, CDK12, or a combination thereof, or as an ALT+ cancer. Also disclosed are methods of inducing cell death in an aberrant cancer cell having a loss of function of ATM, BRCA2, RNAse H2A, RNAse H2B, CDK12, or a combination thereof, or an ALT+ cancer cell, by contacting the cell with an effective amount of an ATR inhibitor and PARP inhibitor.
• Oxidative cyclization of N-alkyl-o-methyl-arenesulfonamides to biologically important saccharin derivatives
  作者：Liang Xu、Hong Shu、Ying Liu、Suhong Zhang、Mark L. Trudell

  DOI：10.1016/j.tet.2006.05.038

  日期：2006.8

  Various biologically important saccharin skeletons and their N-alkyl derivatives have been efficiently prepared by chromium(VI) oxide catalyzed H5IO6 oxidation of N-alkyl-o-methyl-arenesulfonamides in acetonitrile. N-tert-Butyl saccharin skeletons were easily prepared by H5IO6-CrO3 oxidation of N-tert-butyl-o-methyl arenesulfonamides in the presence of acetic anhydride. The method that furnished the novel fluoro and trifluoromethyl substituted saccharin skeletons is characterized by two steps, a simple work-up procedure, a single purification and good overall yields from substituted toluene derivatives. (c) 2006 Elsevier Ltd. All rights reserved.